CMS certification 060023
Intermountain Health St. Mary's Regional Hospital
2635 N 7th St, Grand Junction, CO 81501
Intermountain Health St. Mary's Regional Hospital has a CMS overall rating of 4 out of 5 stars. 72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 1. Emergency patients spend a median of 3 h 22 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 980 completed surveys, 26% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | CO | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 336 visits sampled · US median for EDs of the same volume: 3 h 22 min | 3 h 22 min | 2 h 14 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 42 visits sampled | 4 h 42 min | 3 h 55 min | 4 h 17 min |
| Left before being seen Lower is better · 41,743 patients | 2% | 1% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 287 patients | 62% | 72% | 65% |
How Intermountain Health St. Mary's Regional Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Intermountain Health St. Mary's Regional HospitalThis hospital | 4/5 | 72% | 3 h 22 min | 4 better 1 worse |
| Grand Junction VA Medical CenterSame city | 5/5 | 81% | — | 1 better |
| Community HospitalSame city | 4/5 | 82% | 2 h 15 min | 1 better |
| Family Health West HospitalSame county · Fruita | Not rated | 88% | 48 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Grand Junction.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 2,987 cases | Too few cases | 3.1% | 3.9% |
| Heart attack 271 cases | Too few cases | 11.2% | 11.9% |
| Heart failure 232 cases | Too few cases | 13.1% | 11.1% |
| Pneumonia 235 cases | Too few cases | 17.5% | 15.2% |
| Stroke 382 cases | Too few cases | 11.1% | 11.9% |
| COPD 72 cases | Too few cases | 9.2% | 8.6% |
| Heart bypass surgery (CABG) 95 cases | Too few cases | 1.5% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.99 likely 0.69 – 1.29 | 1 |
| After hip or knee replacement 30 cases | Too few cases | 4.8% | 4.1% |
| Deaths after a serious but treatable surgical complication 122 cases | No different | 184.86 per 1,000 likely 138.36 per 1,000 – 231.36 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 4,037 cases | No different | 1.08 per 1,000 likely 0.41 per 1,000 – 1.75 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 4,897 cases | No different | 0.25 per 1,000 likely 0.05 per 1,000 – 0.45 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 5,033 cases | No different | 0.26 per 1,000 likely 0.06 per 1,000 – 0.45 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,781 cases | No different | 3.23 per 1,000 likely 1.84 per 1,000 – 4.62 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 817 cases | No different | 1.6 per 1,000 likely 0.11 per 1,000 – 3.1 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 746 cases | No different | 6.23 per 1,000 likely 0.3 per 1,000 – 12.16 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,953 cases | No different | 3.08 per 1,000 likely 1.2 per 1,000 – 4.96 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 773 cases | No different | 3.86 per 1,000 likely 0.43 per 1,000 – 7.3 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 418 cases | No different | 1.85 per 1,000 likely 0.42 per 1,000 – 3.29 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,161 cases | No different | 0.95 per 1,000 likely 0.03 per 1,000 – 1.87 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 1.03 likely 0.5 – 1.89 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.7 likely 0.33 – 1.33 | 1 |
| Surgical site infections after colon surgery | No different | 1.13 likely 0.41 – 2.5 | 1 |
| MRSA bloodstream infections | No different | 0.21 likely 0.01 – 1.02 | 1 |
| C. diff intestinal infections | Better | 0.22 likely 0.1 – 0.44 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 413 cases | Too few cases | 11.8% | 14.4% |
| Readmitted after heart failure 334 cases | Too few cases | 20.2% | 21.3% |
| Readmitted after pneumonia 368 cases | Too few cases | 16.8% | 17.3% |
| Readmitted after COPD 146 cases | Too few cases | 19.8% | 20% |
| Readmitted after heart bypass surgery 103 cases | Too few cases | 9.6% | 11% |
| Readmitted after hip or knee replacement 29 cases | Too few cases | 5.7% | 5.8% |
| Days back in hospital after a heart attack 303 cases | Too few cases | -24.7 days per 100 | — |
| Days back in hospital after heart failure 256 cases | Too few cases | -37.7 days per 100 | — |
| Days back in hospital after pneumonia 247 cases | Too few cases | -5.9 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 201 cases | No different | 13.5 per 1,000 likely 10.2 per 1,000 – 18.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 133 cases | No different | 10.7 per 100 likely 7.8 per 100 – 14.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 133 cases | No different | 5.5 per 100 likely 3.8 per 100 – 8 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 691 cases | No different | 1.1 likely 0.9 – 1.4 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
159 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 10 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Anesthesiology | 19 |
| Internal Medicine | 12 |
| Pharmacist | 9 |
| Emergency Medicine | 8 |
| Physician Assistant | 8 |
| Diagnostic Radiology | 7 |
| Emergency Medical Services | 7 |
| Family | 7 |
| Critical Care Medicine | 6 |
| Registered Nurse | 6 |
| Anatomic Pathology & Clinical Pathology | 5 |
| Speech-Language Pathologist | 5 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $16,743
- 2020 $36,822
- 2021 $132,482
- 2022 $111,178
- 2023 $207,254
- 2024 $178,658
- 2025 $176,067
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $2,436 | 7 |
| Debt forgiveness | $1,915 | 2 |
| Speaking, teaching and other services | $1,100 | 3 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $82,121 | 4 |
| Mirati Therapeutics, Inc. | $69,119 | 2 |
| Boston Scientific Corporation | $12,062 | 4 |
| Abbvie INC. | $7,315 | 1 |
| Smith+Nephew, Inc. | $2,023 | 4 |
| Fisher Scientific Company L.L.C. | $1,915 | 2 |
| Tandem Diabetes Care, Inc. | $1,100 | 3 |
| Stryker Corporation | $413 | 3 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 Mirati Therapeutics, Inc. · NCT03785249 | $62,322 |
| A Phase III Double-blind Randomised Placebo-Controlled International Study to assess the Efficacy and Safety of Adjuvant Osimertinib versus Placebo i… AstraZeneca Pharmaceuticals LP | $48,083 |
| A Randomised, Multicentre, Double-Blind, Phase III study will evaluate the safety and efficacy of AZD9833 next generation oral SERD in combination w… AstraZeneca Pharmaceuticals LP | $21,007 |
| US DBS REGISTRY Boston Scientific Corporation · NCT02071134 | $12,062 |
| A Phase 3 Open-label Trial of Neoadjuvant Trastuzumab Deruxtecan (T-DXd) Monotherapy or T-DXd followed by THP Compared to ddAC-THP in Participants wi… AstraZeneca Pharmaceuticals LP | $11,200 |
| Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed Re… ABBVIE INC. | $7,315 |
| A Randomized Phase 3 Study of Sitravatinib in Combination With Nivolumab Versus Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung … Mirati Therapeutics, Inc. · NCT03906071 | $6,797 |
| A Phase 3 Open-label Randomised Study of Datopotamab Deruxtecan (Dato DXd) Versus Investigators Choice of Chemotherapy in Patients who are not Candid… AstraZeneca Pharmaceuticals LP | $1,832 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Intermountain Health St. Mary's Regional Hospital
Is Intermountain Health St. Mary's Regional Hospital a good hospital?
Intermountain Health St. Mary's Regional Hospital has a CMS overall rating of 4 out of 5 stars. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Intermountain Health St. Mary's Regional Hospital?
72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 980 completed HCAHPS surveys.
How long is the wait in the Intermountain Health St. Mary's Regional Hospital emergency room?
Emergency patients spend a median of 3 h 22 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Intermountain Health St. Mary's Regional Hospital receive money from drug and device companies?
Drug and device makers reported $176,067 in payments to Intermountain Health St. Mary's Regional Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.